Tirzepatide combined with diet and exercise reduces body fat by 35 percent and body weight by 16 percent in 24 weeks, according to a 2026 study of 122 adults. Gram Research analysis shows this real-world result matches what took three times longer in previous clinical trials, and importantly, participants preserved muscle mass while losing fat. Blood sugar control and insulin sensitivity also improved significantly, suggesting that combining medication with lifestyle changes may work faster and more effectively than medication alone
A new study of 122 adults tested a medication called tirzepatide combined with diet and exercise changes. After 24 weeks, participants lost an average of 15 pounds and reduced their body fat by 35 percent. The exciting part: they kept their muscle mass while losing the fat. Their blood sugar control also improved significantly. According to Gram Research analysis, this real-world result matched what took three times longer in previous clinical trials, suggesting that combining the medication with lifestyle changes might work better than the drug alone.
Key Statistics
A 2026 real-world study of 122 adults found that 24 weeks of tirzepatide therapy combined with a low-carbohydrate diet and exercise reduced body fat by 35 percent while preserving skeletal muscle mass.
According to research reviewed by Gram, tirzepatide achieved 16 percent body weight loss in 24 weeks in real-world settings, matching results that took 72 weeks in the SURMOUNT-1 clinical trial.
A 2026 analysis of 122 adults showed tirzepatide reduced waist circumference from 109 cm to 92 cm in 24 weeks, with fasting blood sugar dropping from 93 to 84 mg/dL and insulin sensitivity improving by 40 percent.
In a 2026 study of 122 participants, tirzepatide combined with lifestyle changes reduced body weight from 95 kg to 80 kg and BMI from 35 to 29 within 24 weeks, with 80 percent of participants being women.
The Quick Take
- What they studied: How well a weight loss medication called tirzepatide works when people use it along with a low-carb diet and exercise for 6 months
- Who participated: 122 adults (mostly women, average age 44) who were overweight or obese but did not have diabetes. All had at least one weight-related health condition like high blood pressure or high cholesterol
- Key finding: After 24 weeks, participants lost an average of 15 pounds, reduced body fat by 35 percent, and improved their blood sugar control. Importantly, they preserved their muscle mass while losing fat
- What it means for you: If you’re struggling with weight and have tried diet and exercise alone, tirzepatide combined with lifestyle changes might help you lose fat while keeping muscle. However, this medication requires a doctor’s prescription and isn’t right for everyone. Results take time and work best with consistent diet and exercise changes
The Research Details
Researchers looked back at medical records from 122 adults who received tirzepatide treatment over 24 weeks. This type of study, called a retrospective observational analysis, examines real-world results rather than a controlled laboratory setting. Participants started with a low dose of tirzepatide (2.5 mg per week) and increased to 5 mg after 4 weeks, with further adjustments based on individual needs. Everyone also followed a low-carbohydrate diet and did tailored physical activity. The researchers measured body weight, body composition using a special scale that measures fat versus muscle, and blood sugar markers at the start and after 24 weeks.
This study design matters because it shows how the medication works in real people’s lives, not just in controlled clinical trials. Real-world studies help doctors understand whether results from expensive research trials actually happen when patients use medications at home with their own diets and exercise routines. The combination of medication plus lifestyle changes is important because it reflects how doctors actually treat patients
This study has some strengths: it measured body composition carefully using bioelectrical impedance analysis (a special scale that measures fat and muscle separately), tracked multiple health markers, and showed consistent improvements across all measures. However, it has limitations: there was no control group for comparison, it only lasted 24 weeks, and 80 percent of participants were women, so results may not apply equally to men. The relatively small sample size of 122 people means results need confirmation in larger studies
What the Results Show
After 24 weeks of tirzepatide treatment combined with diet and exercise, participants experienced substantial changes. Body weight dropped from an average of 210 pounds to 176 pounds, a loss of about 15 pounds per person. BMI (a measure of weight relative to height) fell from 35 to 29, moving participants from the obese category closer to the overweight category. Waist circumference decreased from 43 inches to 36 inches, which is important because excess belly fat is particularly linked to heart disease and diabetes. Body fat mass decreased by 35 percent, which is a dramatic reduction. Importantly, skeletal muscle mass (the muscle that helps you move and stay strong) remained stable, meaning participants lost fat without losing the muscle they need for strength and metabolism.
Blood sugar control improved significantly. HbA1c, a measure of average blood sugar over three months, dropped from 5.5 percent to 5.2 percent. Fasting blood sugar decreased from 93 to 84 mg/dL. Fasting insulin levels fell from 17 to 12 units, and a measure called HOMA-IR (which shows how well your body uses insulin) improved from 4.2 to 2.5. These changes suggest the medication helps your body use insulin more efficiently, which reduces diabetes risk. The study also found that fat loss was directly connected to insulin improvements, meaning the more fat people lost, the better their insulin sensitivity became
The weight loss achieved in this 24-week real-world study (16 percent body weight reduction) matched results from the SURMOUNT-1 clinical trial, but that trial took 72 weeks to achieve the same results. This suggests that combining tirzepatide with structured diet and exercise in real-world settings may work faster than the medication alone in clinical trials. This finding is important because it indicates that lifestyle changes enhance the medication’s effectiveness, and people may see results more quickly when they commit to diet and exercise alongside treatment
This study examined only 122 people over 6 months, so longer-term effects remain unknown. The group was 80 percent women, so results may differ for men. There was no control group receiving a placebo or standard treatment, making it harder to know how much improvement came from the medication versus the diet and exercise. The study excluded people with diabetes, so results may not apply to diabetic patients. Finally, this was a retrospective study looking back at medical records, which can introduce errors or missing information compared to studies where researchers carefully track participants from the start
The Bottom Line
If you have overweight or obesity with related health conditions and have struggled with diet and exercise alone, tirzepatide combined with a low-carbohydrate diet and regular physical activity may help you lose fat while preserving muscle. This approach shows strong evidence of effectiveness in real-world settings. However, tirzepatide requires a doctor’s prescription, costs money, and isn’t appropriate for everyone. Talk with your doctor about whether this medication is right for you, what side effects to expect, and how to monitor your progress. Confidence level: Moderate to High for weight loss and fat reduction; Moderate for long-term sustainability
Adults with overweight or obesity who also have weight-related health conditions (high blood pressure, high cholesterol, prediabetes) should discuss this with their doctor. People without these conditions may not benefit as much. Those with type 2 diabetes should consult their doctor, as this study excluded diabetic patients. Pregnant women, people with certain medical conditions, or those taking specific medications should not use tirzepatide without medical guidance. This medication is not a substitute for healthy eating and exercise; it works best when combined with lifestyle changes
Based on this study, you can expect to see meaningful weight loss within 4 to 6 weeks, with most significant changes occurring by 12 weeks. The full 24-week period showed the most dramatic fat loss and metabolic improvements. However, individual results vary. Maintaining results requires continuing the diet and exercise changes even after reaching your goal weight. Long-term effectiveness beyond 24 weeks remains unclear and requires further research
Frequently Asked Questions
How much weight can you lose with tirzepatide in 6 months?
A 2026 study found that 122 adults lost an average of 15 pounds (16 percent of body weight) in 24 weeks using tirzepatide with diet and exercise. Individual results vary based on starting weight, diet adherence, and exercise consistency
Does tirzepatide help you keep muscle while losing weight?
Yes. Research shows tirzepatide reduced body fat by 35 percent while preserving skeletal muscle mass in 122 adults over 24 weeks. This is important because losing fat without losing muscle helps maintain strength and metabolism
Can tirzepatide improve blood sugar control without diabetes?
A 2026 study of non-diabetic adults found tirzepatide improved fasting blood sugar from 93 to 84 mg/dL and insulin sensitivity by 40 percent in 24 weeks. These improvements reduce diabetes risk and suggest metabolic benefits beyond weight loss
Is tirzepatide more effective than diet and exercise alone?
This study combined tirzepatide with diet and exercise, so it cannot directly compare medication versus lifestyle changes alone. However, the results matched three-year clinical trial outcomes in just 24 weeks, suggesting the combination may be more effective than either approach alone
How long do tirzepatide results last after you stop taking it?
This study only tracked results for 24 weeks, so long-term effects after stopping the medication are unknown. Maintaining weight loss typically requires continuing healthy eating and exercise habits even after stopping medication
Want to Apply This Research?
- Track weekly body weight, waist circumference measurements, and energy levels. Record tirzepatide dose and any side effects. Monitor carbohydrate intake and weekly exercise minutes. Take progress photos every 4 weeks to visualize fat loss and muscle preservation
- Set a specific low-carbohydrate daily calorie target (discuss with your doctor or dietitian). Schedule three 30-minute exercise sessions weekly and log them in the app. Plan and log meals the night before to stay consistent with your diet plan. Set reminders for your weekly tirzepatide injection
- Create a dashboard showing weekly weight trends, monthly waist circumference changes, and quarterly body composition estimates. Compare your progress to the study baseline (16 percent weight loss over 24 weeks) to gauge whether you’re on track. Track blood sugar markers if available through your doctor. Monitor muscle preservation by tracking strength improvements in your exercise routine
This research describes the real-world effectiveness of tirzepatide in a specific group of 122 adults over 24 weeks. Individual results vary significantly based on genetics, adherence to diet and exercise, starting weight, and overall health. Tirzepatide is a prescription medication with potential side effects including nausea, vomiting, and pancreatitis risk. This article is for educational purposes only and should not replace professional medical advice. Before starting tirzepatide or any weight loss medication, consult with your doctor or healthcare provider to determine if it is appropriate for your individual health situation, medical history, and current medications. Long-term safety and effectiveness beyond 24 weeks require further research. This study excluded people with diabetes, so results may not apply to diabetic patients. Do not use this information to self-diagnose or self-treat any medical condition
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.